RMTI Rockwell Medical Inc.

2.23
+0.11  (+5%)
Previous Close 2.12
Open 2.17
Price To Book 7.69
Market Cap 153,979,497
Shares 69,049,102
Volume 1,294,093
Short Ratio
Av. Daily Volume 1,786,776
Stock charts supplied by TradingView

NewsSee all news

  1. Rockwell Medical, Inc. Receives FDA Approval for Triferic® AVNU (Ferric Pyrophosphate Citrate), Intravenous Formulation of Triferic for Replacement of Iron and Maintenance of Hemoglobin in Hemodialysis Patients

    – Enhances Triferic platform by providing patients with greater access to Rockwell Medical's innovative therapeutic by expanding administration options for clinicians – – Major milestone supports the potential for

  2. Rockwell Medical, Inc. Confirms Medical Resource Acquisition Group's Director Nominations Are Invalid

    WIXOM, Mich., March 20, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving

  3. Rockwell Medical, Inc. Announces $35 Million Debt Financing Agreement with Innovatus Capital Partners, LLC

    WIXOM, Mich., March 17, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and

  4. Rockwell Medical, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results

    – Company reports positive adoption trends for Dialysate Triferic® (ferric pyrophosphate citrate), highlighted by 77% increase in clinics under contract – -- Signed contract with a Medium-Sized Dialysis Organization

  5. Rockwell Medical Determines Medical Resource Acquisition Group's Director Nominations Are Invalid

    WIXOM, Mich., March 11, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Approved January 26, 2015.
Soluble Ferric Pyrophosphate
Anemia
FDA approval announced date March 27, 2020.
IV Triferic
Anemia

Latest News

  1. Rockwell Medical, Inc. Receives FDA Approval for Triferic® AVNU (Ferric Pyrophosphate Citrate), Intravenous Formulation of Triferic for Replacement of Iron and Maintenance of Hemoglobin in Hemodialysis Patients

    – Enhances Triferic platform by providing patients with greater access to Rockwell Medical's innovative therapeutic by expanding administration options for clinicians – – Major milestone supports the potential for

  2. Rockwell Medical, Inc. Confirms Medical Resource Acquisition Group's Director Nominations Are Invalid

    WIXOM, Mich., March 20, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving

  3. Rockwell Medical, Inc. Announces $35 Million Debt Financing Agreement with Innovatus Capital Partners, LLC

    WIXOM, Mich., March 17, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and

  4. Rockwell Medical, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results

    – Company reports positive adoption trends for Dialysate Triferic® (ferric pyrophosphate citrate), highlighted by 77% increase in clinics under contract – -- Signed contract with a Medium-Sized Dialysis Organization

  5. Rockwell Medical Determines Medical Resource Acquisition Group's Director Nominations Are Invalid

    WIXOM, Mich., March 11, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving

  6. Rockwell Medical Acknowledges Receipt of Communications from Medical Resource Acquisition Group

    WIXOM, Mich., March 10, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving

  7. Rockwell Medical, Inc. Offered $15 Million by Medical Resource Acquisition Group, LLC

    NEW YORK, March 09, 2020 (GLOBE NEWSWIRE) -- Medical Resource Acquisition Group, LLC, (MRAG), an investment firm focused on disruptive technologies in the healthcare space, offered Rockwell Medical, Inc. (NASDAQ:RMTI),

  8. Rockwell Medical, Inc. to Discuss Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020

    WIXOM, Mich., March 04, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the "Company") (NASDAQ:RMTI) today announced that the Company will release its 2019 fourth quarter and full year

  9. ServiceSource Announces Four New Appointments to Board of Directors

    Company appoints Andrew M. Baker, Jane Okun Bomba, John A. Meyer, and Robin L. Smith Additions expand ServiceSource's Board with respected world-class leaders Planned retirement of three directors at the

  10. Rockwell Medical, Inc. Provides Business Update

    -- Continued progress for Triferic® portfolio ---- 77% increase in the number of clinics under contract -- WIXOM, Mich., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical"

  11. Rockwell Medical, Inc. to Present at 2020 BIO CEO & Investor Conference

    WIXOM, Mich., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the

  12. Rockwell Medical Announces Pricing of $7.5 Million Public Offering of Common Stock

    WIXOM, Mich., Feb. 04, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes

  13. Rockwell Medical Announces Proposed Public Offering of Common Stock

    WIXOM, Mich., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes

  14. Rockwell Medical, Inc. Enters into Exclusive License and Supply Agreements with Sun Pharma for the Rights to Commercialize Triferic® in India

    WIXOM, Mich., Jan. 14, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes

  15. Rockwell Medical, Inc. Appoints Russell H. Ellison, MD, MSc, to Board of Directors

    WIXOM, Mich., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving

  16. Rockwell Medical, Inc. to Present at Biotech Showcase 2020

    WIXOM, Mich., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, and Angus Smith,

  17. Rockwell Medical, Inc. to Present at 31st Annual Piper Jaffray Healthcare Conference

    WIXOM, Mich., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the

  18. Rockwell Medical, Inc. Expands Medical Capabilities

    – Company adds experienced medical executive to management team and leading nephrologists to Medical Advisory Board – – Objective to become a leading medical organization in the field of dialysis – WIXOM, Mich., Nov.

  19. Rockwell Medical, Inc. Reports Third Quarter 2019 Financial Results

    – Company reports first full quarter of results for Dialysate Triferic, highlighted by greater than 75% conversion rate from Triferic Evaluation Program –  – Signs leading East Coast academic medical center as first

  20. Rockwell Medical, Inc. to Sponsor Triferic® Exhibitor Spotlight Presentation at American Society of Nephrology Conference

    WIXOM, Mich., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an

  21. Rockwell Medical, Inc. to Discuss Third Quarter 2019 Financial Results on November 11, 2019

    WIXOM, Mich., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the "Company") (NASDAQ:RMTI) today announced that the Company will release its 2019 third quarter financial results on

  22. Rockwell Medical, Inc. Appoints John P. McLaughlin Chairman of the Board of Directors

    WIXOM, Mich., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an

  23. Rockwell Medical, Inc. Provides Business Update

    –  Encouraging progress for Triferic® portfolio – – Conference call at 8:30 am ET on Friday, October 25, 2019 – WIXOM, Mich., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical"

  24. Rockwell Medical, Inc. to Present at 2019 Cantor Global Healthcare Conference

    WIXOM, Mich., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to

  25. Rockwell Medical, Inc. Appoints Industry Veteran John P. McLaughlin to Board of Directors

    WIXOM, Mich., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia,

  26. Rockwell Medical, Inc. to Present at Upcoming September Conferences

    WIXOM, Mich., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to